TLDR A patient developed a blister at the injection site after hepatitis C treatment.
A patient with chronic hepatitis C virus (HCV) infection developed a bullous lesion at the inoculation site after treatment with polyethylene glycol interferon-alpha-2a (PEG-IFN-α-2a). This case added to the known dermatological side effects of PEG-IFN, which included both widespread issues like hair loss, pruritus, and vitiligo, and localized issues such as cutaneous ulcerations and necrosis.
26 citations
,
June 2005 in “Journal of The American Academy of Dermatology” Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.
2 citations
,
October 2018 in “Springer eBooks” Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.
105 citations
,
September 1995 in “Journal of The American Academy of Dermatology” Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.
22 citations
,
January 2012 in “Mediators of inflammation” Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.
5 citations
,
January 2016 in “Journal of The American Academy of Dermatology” Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.
November 2019 in “Harper's Textbook of Pediatric Dermatology” The document is a detailed medical reference on skin and genetic disorders.